LITS — Lite Strategy, Inc.
$1.16-2.52%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for LITS in the TickerWise workspace.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 4
- Website: https://www.litestrategy.com
Latest SEC filings for LITS
Latest LITS news
- Lite Strategy Marks 15 Years of Litecoin with Launch of "Proof of Time" Public Industry Archive Read article
- Stock Traders Purchase High Volume of Lite Strategy Call Options (NASDAQ:LITS) Read article
- Lite Strategy GAAP EPS of -$2.06 Read article
- Lite Strategy Reports Fiscal Year 2026 Financial Results Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.